{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:38:26Z","timestamp":1777005506021,"version":"3.51.4"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903222"],"award-info":[{"award-number":["81903222"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2021JJ70152"],"award-info":[{"award-number":["2021JJ70152"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.intimp.2023.110087","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T07:13:53Z","timestamp":1680074033000},"page":"110087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["d-mannose blocks the interaction between keratinocytes and Th17 cells to alleviate psoriasis by inhibiting HIF-1\u03b1\/CCL20 in mice"],"prefix":"10.1016","volume":"118","author":[{"given":"Qian","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benliang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengshu","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6311-3913","authenticated-orcid":false,"given":"Xingchen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.110087_b0005","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"Boehncke","year":"2015","journal-title":"Psoriasis. Lancet"},{"key":"10.1016\/j.intimp.2023.110087_b0010","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","volume":"2","author":"Greb","year":"2016","journal-title":"Psoriasis. Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.intimp.2023.110087_b0015","doi-asserted-by":"crossref","unstructured":"Lebwohl, M. Psoriasis. Ann Intern Med 2018, 168, ITC49-ITC64, doi:10.7326\/AITC201804030.","DOI":"10.7326\/AITC201804030"},{"key":"10.1016\/j.intimp.2023.110087_b0020","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri2622","article-title":"Skin immune sentinels in health and disease","volume":"9","author":"Nestle","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2023.110087_b0025","first-page":"S2","article-title":"Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine","volume":"33","author":"Alwan","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.intimp.2023.110087_b0030","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.intimp.2023.110087_b0035","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4103\/ijd.IJD_422_18","article-title":"Investigation of immunovascular polymorphisms and intersections in psoriasis","volume":"64","author":"Urganci","year":"2019","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.intimp.2023.110087_b0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cellimm.2016.04.001","article-title":"Hypoxia-inducible factor 1 in autoimmune diseases","volume":"303","author":"Deng","year":"2016","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.intimp.2023.110087_b0045","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/607363","article-title":"Cross talk between proliferative, angiogenic, and cellular mechanisms orchestred by HIF-1alpha in Psoriasis","author":"Torales-Cardena","year":"2015","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.intimp.2023.110087_b0050","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/1566524018666181109121849","article-title":"Role of HIF-1 in cancer progression: novel insights","volume":"18","author":"Pezzuto","year":"2018","journal-title":"A Review. Curr Mol. Med."},{"key":"10.1016\/j.intimp.2023.110087_b0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pharmthera.2017.09.003","article-title":"Hypoxia inducible factor as a therapeutic target for atherosclerosis","volume":"183","author":"Jain","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"88","key":"10.1016\/j.intimp.2023.110087_b0060","first-page":"1474","article-title":"HIF-1: mediator of physiological and pathophysiological responses to hypoxia","volume":"2000","author":"Semenza","year":"1985","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.intimp.2023.110087_b0065","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1600-0560.2009.01264.x","article-title":"Increased HIF-1 alpha immunostaining in psoriasis compared to psoriasiform dermatitides","volume":"36","author":"Ioannou","year":"2009","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.intimp.2023.110087_b0070","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1038\/sj.jid.5700874","article-title":"Upregulation of hypoxia-inducible factors in normal and psoriatic skin","volume":"127","author":"Rosenberger","year":"2007","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.110087_b0075","doi-asserted-by":"crossref","first-page":"e0175459","DOI":"10.1371\/journal.pone.0175459","article-title":"MiR-150 regulates human keratinocyte proliferation in hypoxic conditions through targeting HIF-1alpha and VEGFA: implications for psoriasis treatment","volume":"12","author":"Li","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2023.110087_b0080","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cyto.2013.02.029","article-title":"High serum levels of HIF-1alpha in psoriatic patients correlate with an over-expression of IL-6","volume":"62","author":"Vasilopoulos","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2023.110087_b0085","article-title":"Study on HIF-1alpha Gene translation in psoriatic epidermis with the topical treatment of capsaicin ointment","author":"Yu","year":"2011","journal-title":"ISRN Pharm."},{"key":"10.1016\/j.intimp.2023.110087_b0090","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/exd.13785","article-title":"HIF-1alpha-mediated BMP6 down-regulation leads to hyperproliferation and abnormal differentiation of keratinocytes in vitro","volume":"27","author":"Kim","year":"2018","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.intimp.2023.110087_b0095","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.0022-202X.2004.22735.x","article-title":"Insulin-like growth factor-II regulates the expression of vascular endothelial growth factor by the human keratinocyte cell line HaCaT","volume":"123","author":"Kwon","year":"2004","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.110087_b0100","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/039463200601900405","article-title":"VEGF is likely a key factor in the link between inflammation and angiogenesis in psoriasis: results of an immunohistochemical study","volume":"19","author":"Simonetti","year":"2006","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.intimp.2023.110087_b0105","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.imbio.2019.01.005","article-title":"The CCR6-CCL20 axis in humoral immunity and T-B cell immunobiology","volume":"224","author":"Lee","year":"2019","journal-title":"Immunobiology"},{"key":"10.1016\/j.intimp.2023.110087_b0110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jdermsci.2011.11.007","article-title":"Chemokine receptors in the pathogenesis and therapy of psoriasis","volume":"65","author":"Mabuchi","year":"2012","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.intimp.2023.110087_b0115","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nri3158","article-title":"Standardizing immunophenotyping for the Human Immunology Project","volume":"12","author":"Maecker","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2023.110087_b0120","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4049\/jimmunol.180.1.214","article-title":"Human T cells that are able to produce IL-17 express the chemokine receptor CCR6","volume":"180","author":"Singh","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110087_b0125","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1600-065X.2012.01140.x","article-title":"T-cell trafficking in the central nervous system","volume":"248","author":"Sallusto","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2023.110087_b0130","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fimmu.2013.00194","article-title":"CC Chemokine Ligand 20 and Its Cognate Receptor CCR6 in Mucosal T Cell Immunology and Inflammatory Bowel Disease: odd couple or axis of evil?","volume":"4","author":"Lee","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.110087_b0135","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/nm.4375","article-title":"D-mannose induces regulatory T cells and suppresses immunopathology","volume":"23","author":"Zhang","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2023.110087_b0140","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/glycob\/8.3.285","article-title":"Direct utilization of mannose for mammalian glycoprotein biosynthesis","volume":"8","author":"Alton","year":"1998","journal-title":"Glycobiology"},{"key":"10.1016\/j.intimp.2023.110087_b0145","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbrc.2014.06.021","article-title":"Mannose metabolism: more than meets the eye","volume":"453","author":"Sharma","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2023.110087_b0150","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1016\/j.celrep.2018.08.064","article-title":"Mannose alters gut microbiome, prevents diet-induced obesity, and improves host metabolism","volume":"24","author":"Sharma","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.intimp.2023.110087_b0155","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13578-017-0175-1","article-title":"A good sugar, d-mannose, suppresses autoimmune diabetes","volume":"7","author":"Shi","year":"2017","journal-title":"Cell Biosci."},{"key":"10.1016\/j.intimp.2023.110087_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2019.153974","article-title":"Mannose is an insulin-regulated metabolite reflecting whole-body insulin sensitivity in man","volume":"102","author":"Ferrannini","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.intimp.2023.110087_b0165","article-title":"D-Mannose Regulates Hepatocyte Lipid Metabolism via PI3K\/Akt\/mTOR Signaling pathway and ameliorates hepatic steatosis in alcoholic liver disease","volume":"13","author":"Hu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.110087_b0170","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2107663118","article-title":"d-mannose suppresses oxidative response and blocks phagocytosis in experimental neuroinflammation","volume":"118","author":"Wang","year":"2021","journal-title":"PNAS"},{"key":"10.1016\/j.intimp.2023.110087_b0175","doi-asserted-by":"crossref","unstructured":"Liu, H.; Gu, R.; Zhu, Y.; Lian, X.; Wang, S.; Liu, X.; Ping, Z.; Liu, Y.; Zhou, Y. D-mannose attenuates bone loss in mice via Treg cell proliferation and gut microbiota-dependent anti-inflammatory effects. Ther Adv Chronic Dis 2020, 11, 2040622320912661, doi:10.1177\/2040622320912661.","DOI":"10.1177\/2040622320912661"},{"key":"10.1016\/j.intimp.2023.110087_b0180","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1002\/hep.30677","article-title":"Mannose Phosphate Isomerase and Mannose Regulate Hepatic Stellate Cell Activation and Fibrosis in Zebrafish and Humans","volume":"70","author":"DeRossi","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2023.110087_b0185","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.1038\/s41467-020-20164-6","article-title":"D-mannose suppresses macrophage IL-1beta production","volume":"11","author":"Torretta","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2023.110087_b0190","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jid.2016.09.015","article-title":"Shrinking the psoriasis assessment gap: early gene-expression profiling accurately predicts response to long-term treatment","volume":"137","author":"Correa da Rosa","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.110087_b0195","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba6500","article-title":"Developmental cell programs are co-opted in inflammatory skin disease","volume":"371","author":"Reynolds","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.intimp.2023.110087_b0200","doi-asserted-by":"crossref","unstructured":"Stuart, T.; Butler, A.; Hoffman, P.; Hafemeister, C.; Papalexi, E.; Mauck, W.M., 3rd; Hao, Y.; Stoeckius, M.; Smibert, P.; Satija, R. Comprehensive Integration of Single-Cell Data. Cell 2019, 177, 1888-1902 e1821, doi:10.1016\/j.cell.2019.05.031.","DOI":"10.1016\/j.cell.2019.05.031"},{"key":"10.1016\/j.intimp.2023.110087_b0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239261","article-title":"Phorbol 12-Myristate 13-acetate induced toxicity study and the role of tangeretin in abrogating HIF-1alpha-NF-kappaB Crosstalk In Vitro and In Vivo","volume":"21","author":"Chang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.110087_b0210","article-title":"Acute methotrexate toxicity: a fatal condition in two cases of psoriasis","author":"Jariwala","year":"2014","journal-title":"Case Rep. Dermatol. Med."},{"key":"10.1016\/j.intimp.2023.110087_b0215","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1046\/j.1468-3083.2000.00058.x","article-title":"Methotrexate in psoriasis: 26 years' experience with low-dose long-term treatment","volume":"14","author":"Haustein","year":"2000","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.intimp.2023.110087_b0220","first-page":"38","article-title":"Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy","volume":"22","author":"Kremer","year":"1995","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.intimp.2023.110087_b0225","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.amjms.2017.03.014","article-title":"Methotrexate Hepatotoxicity and the Impact of Nonalcoholic Fatty Liver Disease","volume":"354","author":"Shetty","year":"2017","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.intimp.2023.110087_b0230","first-page":"4","author":"Udalova","year":"2016","journal-title":"Anti-TNF Therapy. Microbiol Spectr"},{"key":"10.1016\/j.intimp.2023.110087_b0235","first-page":"199","article-title":"Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study","volume":"12","author":"Megna","year":"2022","journal-title":"Psoriasis (Auckl)"},{"key":"10.1016\/j.intimp.2023.110087_b0240","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2217\/pgs-2016-0122","article-title":"Pharmacogenetics of ustekinumab in patients with moderate-to-severe plaque psoriasis","volume":"18","author":"Prieto-Perez","year":"2017","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.intimp.2023.110087_b0245","first-page":"127","article-title":"Bimekizumab for the treatment of psoriasis: a review of the current knowledge","volume":"12","author":"Ruggiero","year":"2022","journal-title":"Psoriasis (Auckl)"},{"key":"10.1016\/j.intimp.2023.110087_b0250","doi-asserted-by":"crossref","first-page":"e15667","DOI":"10.1111\/dth.15667","article-title":"Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: Results from an Italian single-center retrospective study in a real-life setting","volume":"35","author":"Megna","year":"2022","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.intimp.2023.110087_b0255","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/ced.14979","article-title":"Anti-interleukin-23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real-world practice","volume":"47","author":"Ruggiero","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.intimp.2023.110087_b0260","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1080\/09546634.2022.2081655","article-title":"Real-world practice indirect comparison between guselkumab, risankizumab, and tildrakizumab: results from an Italian 28-week retrospective study","volume":"33","author":"Megna","year":"2022","journal-title":"J. Dermatolog. Treat."},{"key":"10.1016\/j.intimp.2023.110087_b0265","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40257-022-00679-y","article-title":"Time to relapse after discontinuing systemic treatment for psoriasis: a systematic review","volume":"23","author":"Masson Regnault","year":"2022","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.intimp.2023.110087_b0270","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/jdv.14387","article-title":"Early relapse of psoriasis after stopping brodalumab: a retrospective cohort study in 77 patients","volume":"31","author":"Masson Regnault","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.intimp.2023.110087_b0275","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.jaad.2018.12.018","article-title":"TNF-alpha inhibitor-induced psoriasis: a decade of experience at the Cleveland Clinic","volume":"83","author":"Mazloom","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.intimp.2023.110087_b0280","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41586-018-0729-3","article-title":"Mannose impairs tumour growth and enhances chemotherapy","volume":"563","author":"Gonzalez","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.110087_b0285","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Lande","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.110087_b0290","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/jid.2011.262","article-title":"Human keratinocytes' response to injury upregulates CCL20 and other genes linking innate and adaptive immunity","volume":"132","author":"Kennedy-Crispin","year":"2012","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.110087_b0295","doi-asserted-by":"crossref","first-page":"14470","DOI":"10.1073\/pnas.96.25.14470","article-title":"CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells","volume":"96","author":"Morales","year":"1999","journal-title":"PNAS"},{"key":"10.1016\/j.intimp.2023.110087_b0300","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nm0202-157","article-title":"CCL27-CCR10 interactions regulate T cell-mediated skin inflammation","volume":"8","author":"Homey","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2023.110087_b0305","doi-asserted-by":"crossref","unstructured":"Wang, M.; Zhang, S.; Zheng, G.; Huang, J.; Songyang, Z.; Zhao, X.; Lin, X. Gain-of-Function Mutation of Card14 Leads to Spontaneous Psoriasis-like Skin Inflammation through Enhanced Keratinocyte Response to IL-17A. Immunity 2018, 49, 66-79 e65, doi:10.1016\/j.immuni.2018.05.012.","DOI":"10.1016\/j.immuni.2018.05.012"},{"key":"10.1016\/j.intimp.2023.110087_b0310","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ajhg.2012.03.013","article-title":"Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis","volume":"90","author":"Jordan","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.intimp.2023.110087_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106215","article-title":"Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23\/IL-17A in innate immune cells","volume":"80","author":"Nadeem","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2023.110087_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173088","article-title":"Therapeutic treatment with Ibrutinib attenuates imiquimod-induced psoriasis-like inflammation in mice through downregulation of oxidative and inflammatory mediators in neutrophils and dendritic cells","volume":"877","author":"Al-Harbi","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2023.110087_b0325","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau9657","article-title":"Interleukin-17 receptor D constitutes an alternative receptor for interleukin-17A important in psoriasis-like skin inflammation","volume":"4","author":"Su","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.intimp.2023.110087_b0330","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1038\/jid.2011.234","article-title":"Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis","volume":"131","author":"Carrier","year":"2011","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.110087_b0335","doi-asserted-by":"crossref","unstructured":"Xu, M.; Lu, H.; Lee, Y.H.; Wu, Y.; Liu, K.; Shi, Y.; An, H.; Zhang, J.; Wang, X.; Lai, Y.; et al. An Interleukin-25-Mediated Autoregulatory Circuit in Keratinocytes Plays a Pivotal Role in Psoriatic Skin Inflammation. Immunity 2018, 48, 787-798 e784, doi:10.1016\/j.immuni.2018.03.019.","DOI":"10.1016\/j.immuni.2018.03.019"},{"key":"10.1016\/j.intimp.2023.110087_b0340","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2023.110087_b0345","doi-asserted-by":"crossref","first-page":"18921","DOI":"10.1038\/s41598-019-55062-5","article-title":"The IL17F His161Arg polymorphism, a potential risk locus for psoriasis, increases serum levels of interleukin-17F in an Asian population","volume":"9","author":"Choi","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2023.110087_b0350","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1172\/JCI63451","article-title":"Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk","volume":"122","author":"Tortola","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2023.110087_b0355","doi-asserted-by":"crossref","unstructured":"Ha, H.L.; Wang, H.; Pisitkun, P.; Kim, J.C.; Tassi, I.; Tang, W.; Morasso, M.I.; Udey, M.C.; Siebenlist, U. IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms. Proc Natl Acad Sci U S A 2014, 111, E3422-3431, doi:10.1073\/pnas.1400513111.","DOI":"10.1073\/pnas.1400513111"},{"key":"10.1016\/j.intimp.2023.110087_b0360","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/exd.13148","article-title":"Patch testing of food allergens promotes Th17 and Th2 responses with increased IL-33: a pilot study","volume":"26","author":"Ungar","year":"2017","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.intimp.2023.110087_b0365","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.biochi.2020.09.023","article-title":"Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice","volume":"179","author":"Nadeem","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.intimp.2023.110087_b0370","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.phrs.2015.06.001","article-title":"Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC\/IL-17A pathway modulation","volume":"99","author":"Nadeem","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2023.110087_b0375","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cellsig.2017.02.014","article-title":"GPR43 activation enhances psoriasis-like inflammation through epidermal upregulation of IL-6 and dual oxidase 2 signaling in a murine model","volume":"33","author":"Nadeem","year":"2017","journal-title":"Cell. Signal."},{"key":"10.1016\/j.intimp.2023.110087_b0380","doi-asserted-by":"crossref","first-page":"12460","DOI":"10.1073\/pnas.1704958114","article-title":"Protein engineering of the chemokine CCL20 prevents psoriasiform dermatitis in an IL-23-dependent murine model","volume":"114","author":"Getschman","year":"2017","journal-title":"PNAS"},{"key":"10.1016\/j.intimp.2023.110087_b0385","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.micinf.2014.08.005","article-title":"Transcriptional regulation of CCL20 expression","volume":"16","author":"Zhao","year":"2014","journal-title":"Microbes Infect."},{"key":"10.1016\/j.intimp.2023.110087_b0390","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-4632.2006.02962.x","article-title":"Under-expression of VHL and over-expression of HDAC-1, HIF-1alpha, LL-37, and IAP-2 in affected skin biopsies of patients with psoriasis","volume":"46","author":"Tovar-Castillo","year":"2007","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.intimp.2023.110087_b0395","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2613.2009.00669.x","article-title":"Angiogenesis drives psoriasis pathogenesis","volume":"90","author":"Heidenreich","year":"2009","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.intimp.2023.110087_b0400","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/j.freeradbiomed.2011.08.027","article-title":"Regulation of skin inflammation and angiogenesis by EC-SOD via HIF-1alpha and NF-kappaB pathways","volume":"51","author":"Kim","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2023.110087_b0405","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/exd.13548","article-title":"A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis","volume":"27","author":"Bruck","year":"2018","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.intimp.2023.110087_b0410","doi-asserted-by":"crossref","first-page":"7397","DOI":"10.1039\/D2TB00614F","article-title":"Latest on biomaterial-based therapies for topical treatment of psoriasis","volume":"10","author":"Chen","year":"2022","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.intimp.2023.110087_b0415","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40257-021-00649-w","article-title":"New Topical Therapies for Psoriasis","volume":"23","author":"Le","year":"2022","journal-title":"Am. J. Clin. Dermatol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923004083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923004083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:50:14Z","timestamp":1761587414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923004083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":83,"alternative-id":["S1567576923004083"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110087","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"d-mannose blocks the interaction between keratinocytes and Th17 cells to alleviate psoriasis by inhibiting HIF-1\u03b1\/CCL20 in mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110087"}}